These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22935960)

  • 1. N-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial.
    Treweeke AT; Winterburn TJ; Mackenzie I; Barrett F; Barr C; Rushworth GF; Dransfield I; MacRury SM; Megson IL
    Diabetologia; 2012 Nov; 55(11):2920-8. PubMed ID: 22935960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes.
    Gibson KR; Winterburn TJ; Barrett F; Sharma S; MacRury SM; Megson IL
    Cardiovasc Diabetol; 2011 May; 10():43. PubMed ID: 21600014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the antioxidant properties of N-acetylcysteine in human platelets: prerequisite for bioconversion to glutathione for antioxidant and antiplatelet activity.
    Gibson KR; Neilson IL; Barrett F; Winterburn TJ; Sharma S; MacRury SM; Megson IL
    J Cardiovasc Pharmacol; 2009 Oct; 54(4):319-26. PubMed ID: 19668088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term smoking causes nitroglycerin resistance in platelets by depletion of intraplatelet glutathione.
    Haramaki N; Ikeda H; Takajo Y; Katoh A; Kanaya S; Shintani S; Haramaki R; Murohara T; Imaizumi T
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1852-6. PubMed ID: 11701477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.
    Amini M; Salarifar M; Amirbaigloo A; Masoudkabir F; Esfahani F
    Trials; 2009 Jun; 10():45. PubMed ID: 19563648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress.
    Coles LD; Tuite PJ; Öz G; Mishra UR; Kartha RV; Sullivan KM; Cloyd JC; Terpstra M
    J Clin Pharmacol; 2018 Feb; 58(2):158-167. PubMed ID: 28940353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder.
    Wink LK; Adams R; Wang Z; Klaunig JE; Plawecki MH; Posey DJ; McDougle CJ; Erickson CA
    Mol Autism; 2016; 7():26. PubMed ID: 27103982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of radio-labeled N-Acetyl-L-Cysteine in Sprague-Dawley rats and its effect on glutathione metabolism following single and repeat dosing by oral gavage.
    Arfsten DP; Johnson EW; Wilfong ER; Jung AE; Bobb AJ
    Cutan Ocul Toxicol; 2007; 26(2):113-34. PubMed ID: 17612979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylcysteine infusion alters blood redox status but not time to fatigue during intense exercise in humans.
    Medved I; Brown MJ; Bjorksten AR; Leppik JA; Sostaric S; McKenna MJ
    J Appl Physiol (1985); 2003 Apr; 94(4):1572-82. PubMed ID: 12496140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine replenishes glutathione in HIV infection.
    De Rosa SC; Zaretsky MD; Dubs JG; Roederer M; Anderson M; Green A; Mitra D; Watanabe N; Nakamura H; Tjioe I; Deresinski SC; Moore WA; Ela SW; Parks D; Herzenberg LA; Herzenberg LA
    Eur J Clin Invest; 2000 Oct; 30(10):915-29. PubMed ID: 11029607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral N-acetyl cysteine supplementation in type 2 diabetic patients on intracellular glutathione content and innate immune responses to Burkholderia pseudomallei.
    Gamage AM; Lee KO; Gan YH
    Microbes Infect; 2014 Aug; 16(8):661-71. PubMed ID: 25088507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study.
    Girgis RR; Baker S; Mao X; Gil R; Javitt DC; Kantrowitz JT; Gu M; Spielman DM; Ojeil N; Xu X; Abi-Dargham A; Shungu DC; Kegeles LS
    Psychiatry Res; 2019 May; 275():78-85. PubMed ID: 30884334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented oxidative stress of platelets in chronic smokers. Mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet aggregability.
    Takajo Y; Ikeda H; Haramaki N; Murohara T; Imaizumi T
    J Am Coll Cardiol; 2001 Nov; 38(5):1320-7. PubMed ID: 11691502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm.
    Niemi TT; Munsterhjelm E; Pöyhiä R; Hynninen MS; Salmenperä MT
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):29-34. PubMed ID: 16607076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase.
    Haramaki N; Ikeda H; Takenaka K; Katoh A; Sugano R; Yamagishi S; Matsuoka H; Imaizumi T
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1471-7. PubMed ID: 17379842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes.
    De Mattia G; Bravi MC; Laurenti O; Cassone-Faldetta M; Proietti A; De Luca O; Armiento A; Ferri C
    Diabetologia; 1998 Nov; 41(11):1392-6. PubMed ID: 9833950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The application of n-acetylcysteine as an antioxidant and mucolytic in mechanical ventilation in intensive care patients. A prospective, randomized, placebo-controlled, double-blind study].
    Konrad F; Schoenberg MH; Wiedmann H; Kilian J; Georgieff M
    Anaesthesist; 1995 Sep; 44(9):651-8. PubMed ID: 7485927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Acetylcysteine--a safe antidote for cysteine/glutathione deficiency.
    Atkuri KR; Mantovani JJ; Herzenberg LA; Herzenberg LA
    Curr Opin Pharmacol; 2007 Aug; 7(4):355-9. PubMed ID: 17602868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine.
    Laurent T; Markert M; Feihl F; Schaller MD; Perret C
    Chest; 1996 Jan; 109(1):163-6. PubMed ID: 8549180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of oxidative pathways in MS fatigue: randomized trial of N-acetyl cysteine.
    Krysko KM; Bischof A; Nourbakhsh B; Henry RG; Revirajan N; Manguinao M; Nguyen K; Akula A; Li Y; Waubant E
    Ann Clin Transl Neurol; 2021 Apr; 8(4):811-824. PubMed ID: 33675156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.